[go: up one dir, main page]

AU7538100A - Compositions for the treatment of wound contracture - Google Patents

Compositions for the treatment of wound contracture

Info

Publication number
AU7538100A
AU7538100A AU75381/00A AU7538100A AU7538100A AU 7538100 A AU7538100 A AU 7538100A AU 75381/00 A AU75381/00 A AU 75381/00A AU 7538100 A AU7538100 A AU 7538100A AU 7538100 A AU7538100 A AU 7538100A
Authority
AU
Australia
Prior art keywords
compositions
treatment
wound contracture
contracture
wound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75381/00A
Inventor
Breda Mary Cullen
Derek Walter Silcock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Medical Ltd
Original Assignee
Johnson and Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Medical Ltd filed Critical Johnson and Johnson Medical Ltd
Publication of AU7538100A publication Critical patent/AU7538100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Nonwoven Fabrics (AREA)
  • Woven Fabrics (AREA)
AU75381/00A 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture Abandoned AU7538100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9923291 1999-10-01
GB9923291A GB2354708B (en) 1999-10-01 1999-10-01 Compositions for the treatment of wound contracture
PCT/GB2000/003744 WO2001024841A1 (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture

Publications (1)

Publication Number Publication Date
AU7538100A true AU7538100A (en) 2001-05-10

Family

ID=10861983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75381/00A Abandoned AU7538100A (en) 1999-10-01 2000-09-29 Compositions for the treatment of wound contracture

Country Status (5)

Country Link
EP (1) EP1216066A1 (en)
JP (1) JP2003511099A (en)
AU (1) AU7538100A (en)
GB (1) GB2354708B (en)
WO (1) WO2001024841A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2373724B (en) * 2001-03-28 2005-02-02 Johnson & Johnson Medical Ltd Peptides for the treatment of wound contracture
ES2286497T3 (en) * 2002-09-11 2007-12-01 JOHNSON & JOHNSON MEDICAL LTD. PLASTER MATERIALS FOR WOUNDS THAT INCLUDE COMPLEXES OF ANIONIC POLISACARIDS WITH SILVER.
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
EP1601388B1 (en) * 2003-03-10 2011-04-27 Johnson & Johnson Medical Ltd. Hydrocolloid materials for use in wound healing
GB2399289B (en) * 2003-03-10 2006-03-08 Johnson & Johnson Medical Ltd Hydrocolloid materials for use in wound healing
BR112013031537A2 (en) * 2011-06-16 2017-03-01 Unilever Nv aqueous gel.
US8815832B2 (en) 2012-05-25 2014-08-26 Ethicon, Inc. Oxidized regenerated cellulose hemostatic powders and methods of making
CN104368049B (en) * 2014-11-12 2017-02-15 无锡中科光远生物材料有限公司 Haemostatic anti-adhesion composite material of oxycellulose system and preparation method of haemostatic anti-adhesion composite material
CN107530212B (en) * 2015-04-24 2021-10-26 郡是株式会社 Biological tissue reinforcing material
CN105401242A (en) * 2015-10-23 2016-03-16 徐爱军 Medical nonwoven fabric with antibiosis and antiphlogosis efficacy, and preparation method thereof
MX384582B (en) 2015-11-06 2025-03-14 Ethicon Inc Compacted hemostatic cellulosic aggregates
WO2017077526A1 (en) 2015-11-08 2017-05-11 Omrix Biopharmaceuticals Ltd. Hemostatic mixture of cellulose-based short and long fibers
CN107754005B (en) 2016-08-15 2021-06-15 广州倍绣生物技术有限公司 Hemostatic compositions and methods of making same
US11413335B2 (en) 2018-02-13 2022-08-16 Guangzhou Bioseal Biotech Co. Ltd Hemostatic compositions and methods of making thereof
CN111050812B (en) * 2017-10-13 2022-02-25 郡是株式会社 Biological tissue reinforcing material kit and biological tissue reinforcing material

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808599D0 (en) * 1988-04-12 1988-05-11 Glaxo Group Ltd Medicaments
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5414079A (en) * 1993-08-03 1995-05-09 Biocontrol Incorporated Oxidized cellulose
EP0637450A3 (en) * 1993-08-04 1995-04-05 Collagen Corp Composition for revitalizing scar tissue.
US5601579A (en) * 1994-12-29 1997-02-11 Medex, Inc. Method for the treatment of bowel adhesions
US5696101A (en) * 1996-04-16 1997-12-09 Eastman Chemical Company Oxidized cellulose and vitamin E blend for topical hemostatic applications
GB2314840B (en) * 1996-06-28 2000-09-06 Johnson & Johnson Medical Oxidized oligosaccharides and pharmaceutical compositions
US6500777B1 (en) * 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
GB2314842B (en) * 1996-06-28 2001-01-17 Johnson & Johnson Medical Collagen-oxidized regenerated cellulose complexes
US5795286A (en) * 1996-08-15 1998-08-18 Cathco, Inc. Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation

Also Published As

Publication number Publication date
WO2001024841A1 (en) 2001-04-12
GB2354708A (en) 2001-04-04
GB2354708B (en) 2004-06-02
EP1216066A1 (en) 2002-06-26
GB9923291D0 (en) 1999-12-08
JP2003511099A (en) 2003-03-25

Similar Documents

Publication Publication Date Title
AU2935200A (en) Compounds for the treatment of obesity
AU2001272849A1 (en) Composition for the treatment of osteoarthritis
AU2495200A (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2002341729A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
AU6157700A (en) Malodour treatment compositions
AU5547000A (en) Novel treatment
AU7538100A (en) Compositions for the treatment of wound contracture
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
AU2001253749A1 (en) 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
AU1702301A (en) Hair treatment composition
AU2001293891A1 (en) New combination for the treatment of asthma
AU2021601A (en) Composition for the treatment of dandruff
AU1878201A (en) Composition for the treatment of damaged tissue
AU4556800A (en) Novel treatment
AU3814599A (en) Use of erythropoietin for the treatment of haemochromatoses
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU5704800A (en) Medicinal compositions for preventing or treating diarrhea
AU2683500A (en) Compositions for the treatment of pain
AU3759800A (en) Treatment of premenstrual syndrome
AU5416500A (en) Pharmaceutical composition for the treatment of calcification
AU4920200A (en) Compositions for the preserving treatment of feeds
AU1748001A (en) Pharmaceutical composition for treatment of diarrhea
AU4144900A (en) Method of the utilization of bactericidal composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase